SURAKSHA DIAGNOSTIC
Back to Income Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹24 Cr | ₹6.52 Cr | ₹24 Cr | ₹6.44 Cr | ₹15 Cr |
What is the latest Consolidated Net Profit of SURAKSHA DIAGNOSTIC ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹24 Cr |
Mar2023 | ₹6.52 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹6.44 Cr |
Mar2020 | ₹15 Cr |
How is Consolidated Net Profit of SURAKSHA DIAGNOSTIC Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹24 Cr | 262.58 | |
Mar2023 | ₹6.52 Cr | -72.56 | |
Mar2022 | ₹24 Cr | 269.08 | |
Mar2021 | ₹6.44 Cr | -57.70 | |
Mar2020 | ₹15 Cr | - |
Compare Consolidated Net Profit of peers of SURAKSHA DIAGNOSTIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SURAKSHA DIAGNOSTIC | ₹1,653.7 Cr | -1.8% | -2.7% | NA | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹118,544.0 Cr | -6.2% | 1.5% | 36.5% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹103,375.0 Cr | -5.6% | 2.8% | 16.5% | Stock Analytics | |
FORTIS HEALTHCARE | ₹57,682.6 Cr | -5.1% | 0.7% | 69.9% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹40,989.7 Cr | 0.8% | 10.2% | 60.4% | Stock Analytics | |
GLOBAL HEALTH | ₹35,090.7 Cr | 8.6% | 10.2% | 3.2% | Stock Analytics |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SURAKSHA DIAGNOSTIC | -1.8% |
-2.7% |
|
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses